New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

LGHTvsPBEETF Comparison

ETF 1
LGHT

Langar Global HealthTech ETF

This fund is part of
Healthcare Technology
-0.41%
Full LGHT fund page
VS
ETF 2
PBE

Invesco Dynamic Biotechnology & Genome ETF

This fund is part of
BioTech & Genomics
-0.87%
Full PBE fund page

Langar Global HealthTech ETF (LGHT) belongs to the Healthcare Technology segment. Invesco Dynamic Biotechnology & Genome ETF (PBE) is part of the BioTech & Genomics segment. Both ETFs have the same top 3 sector exposures: and Health Care. LGHT is more expensive with a Total Expense Ratio (TER) of 0.85%, versus 0.58% for PBE. LGHT is down -8.11% year-to-date (YTD) with - in YTD flows. PBE performs better with -7.11% YTD performance, and +$135K in YTD flows. Run a side-by-side ETF comparison of LGHT and PBE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

LGHT vs PBE performance and flow charts

Performance

-6.0-4.0-2.00.02.0%Feb 11Feb 19Feb 26Mar 5Mar 12

Cumulative Flows

-3.5 M-3 M-2.5 M-2 M-1.5 M-1 M-0.5 M0 MFeb 11Feb 19Feb 26Mar 5Mar 12

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 03/11/2026
1M3MYTD1Y3Y5Y
Perf.
LGHT
PBE
-3.87%-5.55%
-8.66%-4.87%
-8.11%-7.11%
-8.02%+17.56%
n/a+26.51%
n/a+3.80%
Flows
LGHT
PBE
--$3M
-$101K+$969K
-+$135K
+$1M-$32M
--$56M
--$39M
Volatility and drawdown
3M1Y3Y5Y
Volatility
LGHT
PBE
+18.35%+19.01%
+21.19%+22.33%
n/a+20.20%
n/a+22.79%
Max drawdown
LGHT
PBE
-12.49%-11.05%
-13.88%-16.18%
n/a-22.21%
n/a-34.74%
Max drawdown duration
LGHT
PBE
63d64d
135d107d
n/a324d
n/a1540d
Trading data

Create an account to view trading data

Join for free
LGHT
PBE
Last sale
3/12/2026 at 1:30 PM
$8.96
$76.18
Previous close
03/12/2026
$9.19
$76.18
Consolidated volume
03/12/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

LGHT
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
LGHT
PBE
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 3/12/2026 at 1:30 PM
Live
Closed
LGHT
PBE
Last price
$8.96
$76.18
1D performance
-2.49%
+0.00%
AuM$3.67 M$240.98 M
E/R0.85%0.58%
Characteristics
LGHT
PBE
Management strategyActivePassive
ProviderLangar Investment ManagementInvesco
Benchmark-Dynamic Biotech & Genome Intellidex Index
N° of holdings2530
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateJanuary 10, 2024June 23, 2005
ESGYesNo
Advertisement
Exposure

Countries

LGHT
USA
77.52%
Other
22.48%
PBE
USA
94.25%
Other
5.75%

Sectors

LGHT
Health Care
69.39%
Other
30.61%
PBE
Health Care
96.95%
Other
3.05%
Advertisement

Diversification

LGHT

Total weight of top 15 holdings out of 15

75.77%
PBE

Total weight of top 15 holdings out of 15

61.48%

Top 15 holdings

Data as of January 31, 2026
LGHT
INTUITIVE SURGICAL
15.06%
RESMED
10.69%
US36266G1076
9.16%
VEEVA SYSTEMS IN
7.72%
IQVIA HOLDINGS INC
7.32%
INSULET
7.29%
BIONTECH SE ADR
3.76%
ZIMMER BIOMET HOLDINGS INC
3.75%
MODERNA INC
2.47%
ALIGN TECHNOLOGY
2.20%
MASIMO
1.71%
DOXIMITY
1.60%
IRHYTHM TECHNOLOGIES
1.14%
ALKERMES
1.03%
PRIVIA HEALTH GROUP
0.89%
PBE
ILLUMINA
5.91%
GILEAD SCIENCES
5.35%
AMGEN-T
5.09%
REGENERON PHARMACEUTICALS
4.87%
UTD THERAPEUT
4.83%
BIOGEN INC
4.76%
INCYTE
4.70%
ALNYLAM PHARMACEUTICALS
4.05%
AMICUS THERAPEUTICS
3.83%
DYNAVAX TECHNOLOGIES
3.60%
NL0015002SN0
3.05%
ACADIA PHARMACEUTICALS
2.98%
MANNKIND
2.89%
BIO-TECHNE CORP
2.83%
EXELIXIS
2.74%
Frequently asked questions about LGHT and PBE

How have the LGHT and PBE ETFs performed in 2026?

As of March 11, 2026, LGHT is down -8.11% year-to-date (YTD), while PBE has lost -7.11%. That puts PBE better performer ahead so far this year.

Which ETF is attracting more investor money: LGHT or PBE?

Year-to-date, the LGHT ETF saw - in flows, compared to +$135K for PBE.

Which ETF is more volatile: LGHT or PBE?

Over the past year, LGHT had a volatility of 21.19%, while PBE experienced 22.33%.

Which ETF is bigger: LGHT or PBE?

As of March 11, 2026, LGHT holds $3.67 M in assets under management (AUM), while PBE manages $240.98 M.

What sectors do the LGHT and PBE ETFs invest in?

LGHT leans toward sectors like Health Care. Meanwhile, PBE focuses on Health Care.

What are the top holdings of the LGHT ETF and PBE ETF?

LGHT top holdings include INTUITIVE SURGICAL, RESMED and US36266G1076. PBE holds in its top three: ILLUMINA, GILEAD SCIENCES and AMGEN-T.

Which ETF is more diversified: LGHT or PBE?

LGHT holds 25 securities with 75.77% of its assets in the top 15. PBE has 30 securities and a top 15 weight of 61.48%.

Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up